Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TYK2 |
| Upstream (Parents) |
|---|
| (<<) CTSF → TYK2 |
| (<<) EEF1E1 → TYK2 |
| (<<) FZD4 → TYK2 |
| (<<) IGFBP3 → TYK2 |
| (<<) IGFBP4 → TYK2 |
| (<<) MAP3K3 → TYK2 |
| (<<) UBE2L6 → TYK2 |
| Downstream (Children) |
|---|
| TYK2 → BBS1 (>>) |
| TYK2 → CASP6 (>>) |
| TYK2 → CSTA (>>) |
| TYK2 → DLAT (>>) |
| TYK2 → DYNC1LI2 (>>) |
| TYK2 → E2F2 (>>) |
| TYK2 → EVX1 (>>) |
| TYK2 → GULP1 (>>) |
| TYK2 → HCN4 (>>) |
| TYK2 → KCTD5 (>>) |
| TYK2 → MYL5 (>>) |
| TYK2 → NFKBIA (>>) |
| TYK2 → NRAS (>>) |
| TYK2 → PDK1 (>>) |
| TYK2 → PGK1 (>>) |
| TYK2 → PIP4K2A (>>) |
| TYK2 → RHOT2 (>>) |
| TYK2 → RYK (>>) |
| TYK2 → TNF (>>) |
| TYK2 → TYRO3 (>>) |
| TYK2 → UBE2I (>>) |
